• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素 II 诱导的心肌肥厚信号转导机制。

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy.

机构信息

Institute of Cardiovascular Sciences & Department of Physiology & Pathophysiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.

出版信息

Cells. 2022 Oct 22;11(21):3336. doi: 10.3390/cells11213336.

DOI:10.3390/cells11213336
PMID:36359731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9657342/
Abstract

Although acute exposure of the heart to angiotensin (Ang II) produces physiological cardiac hypertrophy and chronic exposure results in pathological hypertrophy, the signal transduction mechanisms for these effects are of complex nature. It is now evident that the hypertrophic response is mediated by the activation of Ang type 1 receptors (ATR), whereas the activation of Ang type 2 receptors (ATR) by Ang II and Mas receptors by Ang-(1-7) exerts antihypertrophic effects. Furthermore, ATR-induced activation of phospholipase C for stimulating protein kinase C, influx of Ca through sarcolemmal Ca- channels, release of Ca from the sarcoplasmic reticulum, and activation of sarcolemmal NADPH oxidase 2 for altering cardiomyocytes redox status may be involved in physiological hypertrophy. On the other hand, reduction in the expression of ATR and Mas receptors, the release of growth factors from fibroblasts for the occurrence of fibrosis, and the development of oxidative stress due to activation of mitochondria NADPH oxidase 4 as well as the depression of nuclear factor erythroid-2 activity for the occurrence of Ca-overload and activation of calcineurin may be involved in inducing pathological cardiac hypertrophy. These observations support the view that inhibition of ATR or activation of ATR and Mas receptors as well as depression of oxidative stress may prevent or reverse the Ang II-induced cardiac hypertrophy.

摘要

虽然心脏急性暴露于血管紧张素(Ang II)会产生生理性心肌肥厚,而慢性暴露则会导致病理性心肌肥厚,但这些效应的信号转导机制非常复杂。现在已经很明显,肥厚反应是由 Ang 型 1 受体(ATR)的激活介导的,而 Ang II 激活 Ang 型 2 受体(ATR)和 Ang-(1-7)激活 Mas 受体则产生抗肥厚作用。此外,ATR 诱导的磷脂酶 C 激活以刺激蛋白激酶 C、肌浆网 Ca 通道的 Ca 内流、肌浆网内 Ca 的释放以及肌浆膜 NADPH 氧化酶 2 的激活以改变心肌细胞的氧化还原状态可能参与生理性肥厚。另一方面,ATR 和 Mas 受体表达减少、成纤维细胞中生长因子的释放导致纤维化、线粒体 NADPH 氧化酶 4 的激活导致氧化应激以及核因子红系 2 活性的抑制导致 Ca 过载和钙调神经磷酸酶的激活可能参与诱导病理性心肌肥厚。这些观察结果支持这样的观点,即抑制 ATR 或激活 ATR 和 Mas 受体以及抑制氧化应激可能预防或逆转 Ang II 诱导的心肌肥厚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9684/9657342/d8485f4e3026/cells-11-03336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9684/9657342/e82c5380bf2e/cells-11-03336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9684/9657342/fa4df6f1f52e/cells-11-03336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9684/9657342/d8485f4e3026/cells-11-03336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9684/9657342/e82c5380bf2e/cells-11-03336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9684/9657342/fa4df6f1f52e/cells-11-03336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9684/9657342/d8485f4e3026/cells-11-03336-g003.jpg

相似文献

1
Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy.血管紧张素 II 诱导的心肌肥厚信号转导机制。
Cells. 2022 Oct 22;11(21):3336. doi: 10.3390/cells11213336.
2
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.心脏成纤维细胞衍生的外泌体在激活心肌细胞肾素血管紧张素系统中的关键作用。
J Mol Cell Cardiol. 2015 Dec;89(Pt B):268-79. doi: 10.1016/j.yjmcc.2015.10.022. Epub 2015 Oct 20.
3
Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.α-klotho通过抑制AT1R/β-连环蛋白信号通路来抑制血管紧张素II诱导的心肌肥大。
Biochem Biophys Res Commun. 2016 Apr 29;473(2):455-61. doi: 10.1016/j.bbrc.2016.03.029. Epub 2016 Mar 10.
4
The renin-angiotensin system and experimental heart failure.肾素-血管紧张素系统与实验性心力衰竭
Cardiovasc Res. 1999 Sep;43(4):838-49. doi: 10.1016/s0008-6363(99)00145-5.
5
Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.心脏特异性 Bach1 基因敲除通过抑制血管紧张素 II 型 1 受体表达和 Ca2+/CaMKII 信号通路抑制病理性心肌肥厚。
Cardiovasc Res. 2023 Aug 7;119(9):1842-1855. doi: 10.1093/cvr/cvad086.
6
Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure.不同血管紧张素受体在心肌肥厚和心力衰竭发展中的适应性和失能性作用。
Can J Physiol Pharmacol. 2024 Feb 1;102(2):86-104. doi: 10.1139/cjpp-2023-0226. Epub 2023 Sep 25.
7
Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.核限定的血管紧张素受体介导的信号转导调节心肌细胞基因表达。
J Biol Chem. 2010 Jul 16;285(29):22338-49. doi: 10.1074/jbc.M110.121749. Epub 2010 May 12.
8
Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.腺病毒介导的猪心脏成纤维细胞中人类血管紧张素II 2型受体的过表达和刺激,不会调节细胞增殖、I型胶原蛋白mRNA表达及ERK1/ERK2活性,但会抑制蛋白酪氨酸磷酸酶。
J Mol Med (Berl). 2001 Sep;79(9):510-21. doi: 10.1007/s001090100243.
9
Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.炎症与血管紧张素 II 的相互作用:基于心肌细胞直接转染 AT1R 和 AT2R cDNA 的研究。
Exp Biol Med (Maywood). 2012 Dec;237(12):1394-401. doi: 10.1258/ebm.2012.012212.
10
ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes.活性氧(ROS)和内皮型一氧化氮合酶(eNOS)依赖的血管紧张素II 2型受体转运在心肌细胞中产生神经元型一氧化氮合酶。
Basic Res Cardiol. 2015 May;110(3):21. doi: 10.1007/s00395-015-0477-6. Epub 2015 Mar 25.

引用本文的文献

1
Angiotensin-(1-7) Mitigates Progression from Acute Kidney Injury to Chronic Kidney Disease Via Renin-Angiotensin System Modulation in a Murine Model.血管紧张素-(1-7)通过调节小鼠模型中的肾素-血管紧张素系统减轻急性肾损伤向慢性肾病的进展。
Inflammation. 2025 Aug 26. doi: 10.1007/s10753-025-02341-1.
2
Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies.射血分数保留的心力衰竭与肥胖:新兴的代谢治疗策略
Diabetol Metab Syndr. 2025 Aug 18;17(1):336. doi: 10.1186/s13098-025-01917-z.
3
Role of the renin-angiotensin pathway in epilepsy: a strategy for its management by drug repurposing.

本文引用的文献

1
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update.血管紧张素II在心血管系统中的多中心信号传导洞察:最新进展
Front Pharmacol. 2021 Aug 20;12:734917. doi: 10.3389/fphar.2021.734917. eCollection 2021.
2
Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure.氧化应激作为心脏肥大和心力衰竭功能改变的一种机制
Antioxidants (Basel). 2021 Jun 8;10(6):931. doi: 10.3390/antiox10060931.
3
Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III.
肾素-血管紧张素途径在癫痫中的作用:通过药物重新利用进行管理的策略。
Mol Biol Rep. 2025 Jul 10;52(1):695. doi: 10.1007/s11033-025-10776-w.
4
Involvement of Oxidative Stress in Mitochondrial Abnormalities During the Development of Heart Disease.氧化应激在心脏病发生发展过程中线粒体异常中的作用
Biomedicines. 2025 May 29;13(6):1338. doi: 10.3390/biomedicines13061338.
5
hiPSC-derived cardiac fibroblasts dynamically enhance the mechanical function of hiPSC-derived cardiomyocytes on an engineered substrate.人诱导多能干细胞来源的心脏成纤维细胞在工程化基质上动态增强人诱导多能干细胞来源的心肌细胞的机械功能。
Front Bioeng Biotechnol. 2025 May 23;13:1546483. doi: 10.3389/fbioe.2025.1546483. eCollection 2025.
6
METTL3-mediated m⁶A methylation in cardiac diseases: pathogenic roles and therapeutic potential.METTL3介导的m⁶A甲基化在心脏疾病中的致病作用及治疗潜力
Cell Biol Toxicol. 2025 May 20;41(1):87. doi: 10.1007/s10565-025-10039-1.
7
Inhibition of the Renin-Angiotensin System Improves Hemodynamic Function of the Diabetic Rat Heart by Restoring Intracellular Calcium Regulation.抑制肾素-血管紧张素系统可通过恢复细胞内钙调节来改善糖尿病大鼠心脏的血流动力学功能。
Biomedicines. 2025 Mar 20;13(3):757. doi: 10.3390/biomedicines13030757.
8
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy.信号通路在肥厚型心肌病心肌纤维化中的作用
Rev Cardiovasc Med. 2025 Feb 21;26(2):27152. doi: 10.31083/RCM27152. eCollection 2025 Feb.
9
MiR-133b-3p attenuates angiotensin II-induced cardiac hypertrophy through the inhibition of apoptosis by targeting .微小RNA-133b-3p通过靶向抑制凋亡减轻血管紧张素II诱导的心肌肥大。
Acta Biochim Biophys Sin (Shanghai). 2025 Feb 12;57(6):916-926. doi: 10.3724/abbs.2024181.
10
A perspective on small molecules targeting the renin-angiotensin-aldosterone system and their utility in cardiovascular diseases: exploring the structural insights for rational drug discovery and development.靶向肾素-血管紧张素-醛固酮系统的小分子及其在心血管疾病中的应用前景:探索合理药物发现与开发的结构见解
RSC Med Chem. 2025 Jan 21. doi: 10.1039/d4md00720d.
PI3激酶在血管紧张素II诱导的心肌肥大中的作用:I类与III类
Front Pharmacol. 2021 Feb 16;12:608523. doi: 10.3389/fphar.2021.608523. eCollection 2021.
4
Scoparone alleviates Ang II-induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress.山苍子素通过抑制氧化应激缓解血管紧张素Ⅱ诱导的病理性心肌肥厚。
J Cell Mol Med. 2021 Mar;25(6):3136-3148. doi: 10.1111/jcmm.16304. Epub 2021 Feb 9.
5
NRF2 in Cardiovascular Diseases: a Ray of Hope!NRF2 在心血管疾病中的作用:一线希望!
J Cardiovasc Transl Res. 2021 Jun;14(3):573-586. doi: 10.1007/s12265-020-10083-8. Epub 2020 Nov 25.
6
Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect.沙库巴曲缬沙坦在不依赖降压作用的情况下抑制血管紧张素II诱导的高血压小鼠心肌细胞肥大。
Cardiol Res. 2020 Dec;11(6):376-385. doi: 10.14740/cr1137. Epub 2020 Nov 2.
7
Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy.新型 Pterosin B 对血管紧张素 II 诱导的心肌细胞肥大的治疗作用。
Molecules. 2020 Nov 12;25(22):5279. doi: 10.3390/molecules25225279.
8
Ca-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production.钙依赖性 NADPH 氧化酶 5(NOX5)通过活性氧物质的产生加剧心肌肥厚。
Hypertension. 2020 Sep;76(3):827-838. doi: 10.1161/HYPERTENSIONAHA.120.15558. Epub 2020 Jul 20.
9
Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.类固醇生成急性调节蛋白/醛固酮合酶介导血管紧张素 II 诱导的心脏纤维化和肥大。
Mol Biol Rep. 2020 Feb;47(2):1207-1222. doi: 10.1007/s11033-019-05222-7. Epub 2019 Dec 9.
10
Mechanisms for the transition from physiological to pathological cardiac hypertrophy.从生理性心脏肥大转变为病理性心脏肥大的机制。
Can J Physiol Pharmacol. 2020 Feb;98(2):74-84. doi: 10.1139/cjpp-2019-0566.